~~<i id='8EA3D2582E'><strike id='8EA3D2582E'><tt id='8EA3D2582E'><pre id='8EA3D2582E'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

knowledge

comprehensive

author：hotspot 2025-10-04 10:47:53 - browse：381

LONDON — GSK said Tuesday it would purchase the asthma-focused drug developer Aiolos Bio for $1 billion upfront, the latest in a string of pharma acquisitions that are bolstering hopes for the industry’s year ahead.

The deal includes up to another $400 million in payments if certain milestones are met.

Aiolos was launched just last year, based in both San Francisco and London. The company, which announced a $245 million Series A round in October, has been readying a Phase 2 trial of its candidate AIO-001 in adult asthma.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： In Memoriam: Notable people who died in 2023
Next article： Why health care costs have stayed mostly flat since 2010

focus

hotspot

Wikipedia

entertainment

focus

StaffandvolunteersattheHungryMonkfoodpantryprepareanddistributefruitandvegetablestolocalresidentsatt

WSS

STAT Health News: Apple Watch import ban, Pfizer fumbles, etc

'CMA Fest' 2023: How to watch, who is performing and more

In Spain, a hospital brews its own CAR

In Spain, a hospital brews its own CAR

The stock market has soared this year, but will it last? Experts weigh in

Sanders wants to replace patents with prizes for drug inventions

knowledge

comprehensive

focus

Cancer drug shortages should be causing more outrage

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Medicare details structure of new drug price negotiation program

Thousands of UK hospital doctors walk out in the latest pay dispute, crippling health services

At least 13 dead in Texas as scorching temps continue

What STAT readers think about the FDA and patient advocacy

Bright Health sells Medicare Advantage business to Molina

A woman pleads guilty to fire that kept a Wyoming abortion clinic from opening for a year

Duchenne breakthrough therapy leaves behind pioneering families

Are infertility treatments 'essential' during the Covid

hotspot

Violet CEO on training clinicians to promote more inclusive care

Extensive review finds private equity owners jack up cost of care

How a Boston hospital is priming medical residents to use GPT

Can sheer will power keep patients alive in their dying hours?

Telehealth startups are trying to fill the menopause care vacuum

Headers linked to memory issues, raising questions about soccer safety as the World Cup kicks off

hotspot

Wikipedia

entertainment

focus